The Effects of Administrated Sildenafil Citrate on Uterine Luminal Epithelium Height Associated with Ovarian Angiogenesis: An Experimental Animal Study

Document Type : Original Article

Authors
Mohammad Hosein Golkar 1
Mohammad Javad Saeedi Borujeni 2
Bahman Rashidi 2
1 Student Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Molecular Biology and Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: Ovarian angiogenesis (OA) remains in lifetime and normal ovarian function depends to this continual remodeling of a complex vascular system. Endometrial thickness (ET) is one of the strongest predictors of successful implantation and pregnancy. Appropriate OA effects on ET by facilitating of ovarian hormone delivery. Materials and Methods: Thirty adult female mice and twenty adult male mice were purchased. The female mice were divided into three groups: (1) control group without any intervention (n = 10), (2) gonadotropin group: receiving human menopausal gonadotropin (HMG) and human chorionic gonadotropin (n = 10), and (3) gonadotropin and sildenafil citrate (SC) group: receiving HMG and SC administration (n = 10). After mating, animals were deeply anesthetized, and the ovary and uterus was rapidly removed for histology and immunohistochemistry process. Results: Four days after ovarian induction, all three layers of the uterus with specified thickness can be clearly seen. The heights of endometrial epithelial cells in gonadotropin group were not significantly different than those in control group. In gonadotropin and SC group, heights of the cells were significantly (P < 0.05) shorter than control and gonadotropin groups. ETs in all groups were not significantly deferent from each other (P > 0.05 each). Our results of immunohistochemistry survey for ovarian CD31 demonstrated that administrated SC increased OA but not significantly (P > 0.05 each). Conclusion: It may finally conclude that administration of SC does not cause notable alterations in OA and ET; although for realistic decision about the SC effects on aforementioned parameters, more molecular investigations and longer drug consumption period are necessary.

Keywords

1.
Gnainsky Y, Granot I, Aldo PB, Barash A, Or Y, Schechtman E, et al. Local injury of the endometrium induces an inflammatory response that promotes successful implantation. Fertil Steril 2010;94:2030-6.  Back to cited text no. 1
[PUBMED]    
2.
Raziel A, Schachter M, Strassburger D, Bern O, Ron-El R, Friedler S. Favorable influence of local injury to the endometrium in intracytoplasmic sperm injection patients with high-order implantation failure. Fertil Steril 2007;87:198-201.  Back to cited text no. 2
[PUBMED]    
3.
Kitaya K, Matsubayashi H, Takaya Y, Nishiyama R, Yamaguchi K, Ishikawa T. Clinical background affecting pregnancy outcome following local endometrial injury in infertile patients with repeated implantation failure. Gynecol Endocrinol 2016;32:587-90.  Back to cited text no. 3
    
4.
Mangal S, Mehirishi S. To study and compare the effect of vaginal sildenafil and estradiol valerate on endometrial thickness, blood flow and pregnancy rates in infertile women undergoing intrauterine insemination. Int J Reprod Contracept Obstet Gynecol 2017;5:2274-7.  Back to cited text no. 4
    
5.
Zhang X, Chen CH, Confino E, Barnes R, Milad M, Kazer RR. Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization-embryo transfer. Fertil Steril 2005;83:336-40.  Back to cited text no. 5
[PUBMED]    
6.
Kasius A, Smit JG, Torrance HL, Eijkemans MJ, Mol BW, Opmeer BC, et al. Endometrial thickness and pregnancy rates after IVF: A systematic review and meta-analysis. Hum Reprod Update 2014;20:530-41.  Back to cited text no. 6
[PUBMED]    
7.
Rashidi B, Malekzadeh M, Goodarzi M, Masoudifar A, Mirzaei H. Green tea and its anti-angiogenesis effects. Biomed Pharmacother 2017;89:949-56.  Back to cited text no. 7
[PUBMED]    
8.
Rätsep M, Carmeliet P, Adams M, Croy B. Impact of placental growth factor deficiency on early mouse implant site angiogenesis. Placenta. 2014;35(9):772-5.  Back to cited text no. 8
    
9.
Miller JW, Le Couter J, Strauss EC, Ferrara N. Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology 2013;120:106-14.  Back to cited text no. 9
[PUBMED]    
10.
Ramjiawan RR, Griffioen AW, Duda DG. Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? Angiogenesis 2017;20:185-204.  Back to cited text no. 10
    
11.
Han JW, Choi D, Lee MY, Huh YH, Yoon YS. Bone marrow-derived mesenchymal stem cells improve diabetic neuropathy by direct modulation of both angiogenesis and myelination in peripheral nerves. Cell Transplant 2016;25:313-26.  Back to cited text no. 11
[PUBMED]    
12.
Osz K, Ross M, Petrik J. The thrombospondin-1 receptor CD36 is an important mediator of ovarian angiogenesis and folliculogenesis. Reprod Biol Endocrinol 2014;12:21.  Back to cited text no. 12
[PUBMED]    
13.
Hazzard TM, Stouffer RL. Angiogenesis in ovarian follicular and luteal development. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:883-900.  Back to cited text no. 13
[PUBMED]    
14.
Geva E, Jaffe RB. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 2000;74:429-38.  Back to cited text no. 14
[PUBMED]    
15.
Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med 2003;3:643-51.  Back to cited text no. 15
[PUBMED]    
16.
Lange C, Turrero Garcia M, Decimo I, Bifari F, Eelen G, Quaegebeur A, et al. Relief of hypoxia by angiogenesis promotes neural stem cell differentiation by targeting glycolysis. EMBO J 2016;35:924-41.  Back to cited text no. 16
[PUBMED]    
17.
Semenza GL. Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis. Oncogene 2013;32:4057-63.  Back to cited text no. 17
[PUBMED]    
18.
Pacini S, Petrini I. Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells. Front Cell Dev Biol 2014;2:20.  Back to cited text no. 18
[PUBMED]    
19.
Rashidi B, Soleimani Rad JI, Roshangar L, Alizadeh Miran R. Evaluation of pinopodes expression on the mouse endometrium immediately before implantation by treatment with HMG/HCG and sildenafil citrate administration. Iran J Basic Med Sci 2012;15:1091-6.  Back to cited text no. 19
[PUBMED]    
20.
Kniotek M, Boguska A. Sildenafil can affect innate and adaptive immune system in both experimental animals and patients. J Immunol Res 2017;2017:4541958.  Back to cited text no. 20
[PUBMED]    
21.
Zelefsky MJ, Shasha D, Branco RD, Kollmeier M, Baser RE, Pei X, et al. Prophylactic sildenafil citrate improves select aspects of sexual function in men treated with radiotherapy for prostate cancer. The Journal of urology. 2014;192(3):868-74.  Back to cited text no. 21
    
22.
Dehghani Firouzabadi R, Davar R, Hojjat F, Mahdavi M. Effect of sildenafil citrate on endometrial preparation and outcome of frozen-thawed embryo transfer cycles: A randomized clinical trial. Iran J Reprod Med 2013;11:151-8.  Back to cited text no. 22
[PUBMED]    
23.
Celik M, Aksoy AN, Aksoy H, Aksoy Y, Halici Z. Sildenafil reduces ischemia-reperfusion injury in rat ovary: Biochemical and histopathological evaluation. Gynecol Obstet Invest 2014;78:162-7.  Back to cited text no. 23
[PUBMED]    
24.
Saeedi Borujeni MJ, Hami J, Haghir H, Rastin M, Sazegar G. Evaluation of Bax and Bcl-2 proteins expression in the rat hippocampus due to childhood febrile seizure. Iran J Child Neurol 2016;10:53-60.  Back to cited text no. 24
    
25.
Taskin MI, Yay A, Adali E, Balcioglu E, Inceboz U. Protective effects of sildenafil citrate administration on cisplatin-induced ovarian damage in rats. Gynecol Endocrinol 2015;31:272-7.  Back to cited text no. 25
[PUBMED]    
26.
De Palma M, Naldini L. Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis. Biochim Biophys Acta 2006;1766:159-66.  Back to cited text no. 26
[PUBMED]    
27.
Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, et al. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 2006;20:1495-7.  Back to cited text no. 27
[PUBMED]    
28.
Fortune JE, Cushman RA, Wahl CM, Kito S. The primordial to primary follicle transition. Mol Cell Endocrinol 2000;163:53-60.  Back to cited text no. 28
[PUBMED]    
29.
Mor YS, Schenker JG. Ovarian hyperstimulation syndrome and thrombotic events. Am J Reprod Immunol 2014;72:541-8.  Back to cited text no. 29
[PUBMED]    
30.
Lindsay LA, Murphy CR. Ovarian hyperstimulation affects fluid transporters in the uterus: A potential mechanism in uterine receptivity. Reprod Fertil Dev 2014;26:982-90.  Back to cited text no. 30
[PUBMED]    
31.
Sengupta P. The laboratory rat: Relating its age with human's. Int J Prev Med 2013;4:624-30.  Back to cited text no. 31
[PUBMED]    
32.
Rashidi B, Rad JS, Roshangar L, Miran RA. Progesterone and ovarian stimulation control endometrial pinopode expression before implantation in mice. Pathophysiology 2012;19:131-5.  Back to cited text no. 32
[PUBMED]    
33.
Deane JA, Ong YR, Cain JE, Jayasekara WS, Tiwari A, Carlone DL, et al. The mouse endometrium contains epithelial, endothelial and leucocyte populations expressing the stem cell marker telomerase reverse transcriptase. Mol Hum Reprod 2016;22:272-84.  Back to cited text no. 33
[PUBMED]    
34.
Wang L, Qiao J, Li R, Zhen X, Liu Z. Role of endometrial blood flow assessment with color Doppler energy in predicting pregnancy outcome of IVF-ET cycles. Reprod Biol Endocrinol 2010;8:122.  Back to cited text no. 34
[PUBMED]    
35.
Goldstein SR, Archer DF, Simon JA, Constantine G. Endometrial safety of ospemifene and the ability of transvaginal ultrasonography to detect small changes in endometrial thickness. Obstet Gynecol 2014;123:96S-7S.  Back to cited text no. 35
    
36.
Kovacs P, Matyas S, Boda K, Kaali SG. The effect of endometrial thickness on IVF/ICSI outcome. Hum Reprod 2003;18:2337-41.  Back to cited text no. 36
[PUBMED]    
37.
El-Toukhy T, Coomarasamy A, Khairy M, Sunkara K, Seed P, Khalaf Y, et al. The relationship between endometrial thickness and outcome of medicated frozen embryo replacement cycles. Fertil Steril 2008;89:832-9.  Back to cited text no. 37
[PUBMED]    
38.
Mercé LT, Barco MJ, Bau S, Troyano J. Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome? Fertil Steril 2008;89:111-7.  Back to cited text no. 38
    
39.
Gonen Y, Casper RF. Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF). J Assist Reprod Genet 1990;7:146-52.  Back to cited text no. 39
    
40.
Sher G, Herbert C, Maassarani G, Jacobs MH. Assessment of the late proliferative phase endometrium by ultrasonography in patients undergoing in-vitro fertilization and embryo transfer (IVF/ET). Hum Reprod 1991;6:232-7.  Back to cited text no. 40
[PUBMED]    
41.
Rashidi B, Rad JS, Rad LR. Immunohistochemical (Ki-67) study of endometrial maturation in mice after use of phosphodiesterase type 5 inhibitor. Adv Biomed Res 2015;4:154.  Back to cited text no. 41
[PUBMED]  [Full text]  
Advanced Biomedical Research
Volume 2017, December
December 2017
Pages 1-6